Evaxion A (EVAX) Other Non-Current Assets (2019 - 2025)
Evaxion A (EVAX) reported Other Non-Current Assets of $185000.0 for Q4 2025, up 14.2% on a YoY basis from $162000.0 in Q4 2024, and little changed quarter-over-quarter from $185000.0 in Q2 2025.
Evaxion A (EVAX) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Evaxion A has reported Other Non-Current Assets for 7 years, with the latest figure at $185000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 14.2% year-over-year to $185000.0; the trailing twelve-month figure through Dec 2025 stood at $185000.0 (up 14.2% YoY), and the FY2025 full-year result was $185000.0, up 14.2% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $185000.0, roughly flat from $185000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $200000.0 in Q2 2021, with the low at $148000.0 in Q2 2022.
- Historically, Other Non-Current Assets has averaged $175076.9 across 5 years, with a median of $167000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets dropped 26.0% — and 2025, when it advanced 14.2%.
- Evaxion A's Other Non-Current Assets stood at $191000.0 in 2021, then retreated by 18.32% to $156000.0 in 2022, then gained by 7.05% to $167000.0 in 2023, then retreated by 2.99% to $162000.0 in 2024, then grew by 14.2% to $185000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $185000.0 (Q4 2025), $185000.0 (Q2 2025), and $162000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 2.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 185,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Jun 30, 2023 | 165,000.00 |
| Dec 31, 2022 | 156,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 165,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Sep 30, 2021 | 194,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 193,000.00 |
| Dec 31, 2020 | 238,000.00 |
| Dec 31, 2019 | 25,000.00 |